Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06427720
Status:
COMPLETED
Last Update Posted:
2024-05-24
First Post:
2024-05-20
Brief Title:
LINC00511miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis
Sponsor:
Organization:
Ain Shams University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Four milliliters of peripheral blood was withdrawn once from controls and BC patients at the time patients were first diagnosed clinically with BC and before any medical neoadjuvant therapy or surgical intervention under strict sterile conditions following standard biosecurity and international safety procedures into polymer gel vacutainers with a clot activator Greiner Bio-One GmbH Australia left for 15 min at room temperature to clot followed by a 10-min centrifugation at 10000g at 4C Sera obtained were aliquoted into three clean Eppendorf tubes and stored at -80C
Enrollment Count:
95
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 107202 |
Who Masked List: